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Cervical and uterine electromyograms (EMG) have been recorded from ovariectomized
non-pregnant ewes. When the animals were infused with saline, the frequency of EMG events
lasting less than 180 seconds was not different from those lasting more than 180 seconds. During
infusion ofestradiol at 100 ,ug * 24 hours-' into the maternaljugular, the frequency ofevents less
than 180 seconds increased significantly in the myometrium and in the cervix. Contracture
activity (events lasting more than 180 seconds) was not significantly different in the myometrium
compared to the cervix before estradiol administration. During estradiol infusion, the contracture
activity remained unchanged.
During 4-amino-antipyrine (4AA) administration, the contracture activity decreased signifi-
cantly in the myometrium, while an insignificant change occurred in the cervix. This state was
associated with a decrease in the venous PGFM:6-keto Fla plasma ratio. Infusion ofPGF2a (.5 Ig
min-' and 1.0,g * min-' for ten minutes) into the femoral artery resulted in a significant increase
in the frequency of events less than 180 seconds in both the myometrium and cervix. For the
duration ofthe ten-minute infusion, the activity was contracture-like.
These findings suggest that the cervix may not only be influenced by mechanical properties
(stretch) and local paracrine factors but also by various stimulators and inhibitors irrespective of
the myometrium.
INTRODUCTION
Several groups of investigators have described the characteristics of the in vivo
electromyogram (EMG) recorded from the whole myometrium and cervix in the sheep
and other species in both the pregnant and non-pregnant state [1-10]. The indepen-
dence of uterine and cervical motility in the ruminant has been investigated [1]. The
aim of the present study was to describe the characteristics of EMG activity of the
cervix in the ovariectomized non-pregnant ewe, and to investigate the reversal of
4-amino-antipyrine (4AA) effects in the estradiol-replaced ewe by the administration
ofexogenous PGF2,. Cervical and myometrial EMG activity was recorded both before
and during the continuous intravenous administration of estradiol, 4AA, and during
PGF2a treatment. If differences exist, they may throw light on possible different
regulatory mechanisms, enabling us to evaluate possible myogenic (prostacy-
clin:PGF2a ratio) or neurogenic factors acting on the reproductive tract.
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MATERIALS AND METHODS
Experimental Animals andSurgical Procedures
Four non-pregnant Rambouillet-Columbia ewes were used in the study. Four
animals were used because we desired to detect at least a 15 percent change in EMG
activity at (1 - = .80), the .05 significance level. Ewes were premedicated with
800-900 mg of ketamine and .5 mg of glycopyrrolate, administered intramuscularly.
Under halothane anesthesia, bilateral ovariectomy was carried out in all ewes. At least
five days were allowed to elapse after surgery before any infusions were started.
Polyvinyl catheters (1.8 mm, outer diameter; 1.02 mm, inner diameter) were inserted
into one uterine vein on each side through an entry point near the tip of the uterine
horn. The catheters were passed 15 cm in the direction ofthe inferior vena cava so that
the tip of the catheter lay in the main uterine vein. Catheters were also placed in one
jugular vein and carotid artery. A fifth vascular catheter was placed in the femoral
artery on one side and advanced 30 cm into the dorsal aorta.
Myometrial EMG electrodes were fabricated as described previously [2]. Four pairs
of electrodes were placed; two pairs were sewn into the cervix in the region of the
external os and one pair into each uterine horn near itsjunction with the body. In each
pair, the electrodes were 2-3 mm apart.
Infusions
All vascular catheters werecontinuously infused with physiological saline (NaCl 0.9
percent W/V) containing 50 U heparin ml-' at a rate of.5 ml * hour-'. When estradiol
was infused, it was administered to the maternal jugular vein in a solution of 2.5
percent ethanol in physiological saline (V/V) at a rate of 100 ,g estradiol 24-' in
39 ml * 24-'. When 4AA (prostaglandin synthetase inhibitor) was infused, it was
administered to the maternal femoral vein in a solution of 210 * mg ml-' of saline.
Fifteen mg * min-' was infused for four hours. PGF2a was prepared by dissolving .1 ml
of PGF 2a (100 Ag frozen crystal dissolved in .1 ml of saline) into 4.9 ml of saline. To
make up .2 .ug, 2 Aug, 5 tug, and 10 Ag preparations, the 5 ml stock solution was serially
diluted. The PGF2Cr treatment was repeated sequentially for each concentration. The
rates of infusions were .02 jig, .2 ug, .5 gg, and 1.0 jig * min-' for ten minutes,
respectively. It should be noted that PGF2a was used immediately after preparation
because it is unstable in solution. Experimental treatments are presented below. All
four ewes were subjected to all four experimental treatments.
Treatment 1: PGF2a administration without either 4-amino-antipyrine or estra-
diol
Treatment 2: Continuous estradiol infusion (baseline recording 48-72 hours)
Treatment 3: 4AA administration with continuous estradiol infusion
Treatment 4: PGF2a and 4AA administration during continuous estradiol infu-
sion
During continuous estradiol infusion, each animal received an administration ofthe
prostaglandin synthetase inhibitor 4AA at an infusion rate of 15 mg * min-' in the
maternal femoral vein for four hours. Resting samples were obtained from the uterine
vein catheters. Samples were designated as P4 (prostaglandin analysis) and S4
(corticosteroid analysis). Four ml of blood were collected every hour in chilled
heparinized tubes (S4) and EDTA-aspirin tubes (P4), centrifuged for 11 minutes,
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frozen with liquid nitrogen, and then stored until analysis. The EDTA-aspirin was used
to prevent additional production ofprostaglandins in vitro.
As described above, during simultaneous 4AA and estradiol infusion, PGF2a was
administered in the femoral arterial catheter for ten minutes at .02 ,ug, .2 ,ug, .5,ug, and
1.0 jig * min-'. Samples were collected for eight hours and processed as described
above. Sampling was staggered in five-minute and 30-minute intervals with, generally,
a total of 19 samples per animal.
Plasma Prostaglandin Measurements
Blood samples were analyzed from three ewes. PGFM (PGF2a metabolite) and
6-keto Fla (prostacyclin metabolite) titers were determined. The methods ofthe assay
are reported elsewhere [3].
RecordingofEMG Signals and Data Analysis
EMG signals were recorded and stored on a custom-built data acquisition system as
previously described [4]. Individual epochs ofactivity were analyzed for duration and
activity, using a two-hour running mean to set the threshold for distinguishing signal
from noise, and an eight-second delimiter to determine when an epoch was completed.
The EMG recordings were made continuously and analyzed in two-hour time blocks.
In order to relate the present studies to our findings in the pregnant sheep, we have
divided epochsofEMG activity recorded in this study to thoseofduration less than 180
seconds and epochs ofactivity greater than 180 seconds' duration [4]. Forty-eight to 72
hours of data were analyzed for each animal without estradiol administration and at
least 48 hours of data during estradiol administration. Data throughout are given as
means ± SD.
Statistical Analysis Methods
Data were analyzed on the basis of number of events in two-hour time intervals.
Each sheep had recordings available from at least six continuous two-hour time
intervals. The maximum was twenty-three. The data for individual two-hour time
intervals foreach sheep were averaged togivedata points for the full period ofstudy on
that animal on estradiol, 4AA, and PGF2, treatment with or without estradiol. EMG
activity in the cervix and myometrium was compared by the two-independent student
t-test or the Wilcoxan sign rank test when variances differed greatly. Correlations
between plasma prostaglandin concentrations (PGFM:6-keto Fla ratio) and PGF2a
dosages were evaluated using the Pearson's correlation coefficient.
RESULTS
Short-Duration Epochs
In the absence ofestradiol administration there was no significant difference in the
frequency of short epochs between the cervix 76 ± 18 and the myometrium 60 ± 47
(p = .20). During estradiol infusion, the frequency of short epochs in the cervix
increased from 76 ± 18 to 89 ± 22 (p < .05), while it was more significantly increased
in the myometrium from 60 ± 47 to 201 ± 62 (p < .0001); also, the frequency ofshort
epochs was significantly greater in the myometrium-201 ± 62 compared with the
cervix-89 ± 22 (p < .0001). During the administration of 4AA (15 mg * min-' for
four hours), the frequency of short epochs was increased insignificantly in both
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TABLE 1
Frequency of EMG Epochs of <180 Seconds and >180 Seconds Duration per Two-Hour Period,
Recorded from Four Ovariectomized Non-Pregnant Sheep Without and With Estradiol Infusion at
100 ug 24-'
Cervix Myometrium
<180 Seconds >180 Seconds <180 Seconds >180 Seconds
Without E2 76 ± 18 2.0 ± 1.4 60 ± 47 3.0 ± 1.4
With E2 89 ± 22 2.6 ± 0.7 201 ± 62 3.3 ± 1.5
myometrium-from 66 ± 19 to 74 ± 17 (p = .37)-and the cervix from 81 ± 28
without 4AA to 84 ± 22 (p = .54) with 4AA (Tables 1 and 2).
Contracture Activity
In the absence of estradiol, the difference between the frequency of contractures
(epochs > 180 seconds) in the cervix (2.0 ± 1.4) and in the myometrium (3.0 ± 1.4)
was insignificant (p = .32). During estradiol administration, contracture frequency
did not change significantly in either the myometrium-3.0 ± 1.4 to 3.3 ± 1.5
(p = .80), or in the cervix-2.0 ± 1.4 to 2.6 ± .65 (p = .53) (Table 1). During 4AA
administration (Table 2), however, contracture frequency decreased significantly in
the myometrium-2.8 ± 1.5 to 1.0 ± .8 (p < .02) but was not changed significantly in
the cervix 1.5 ± 1.6 to 1.1 ± .9 (p = .49) (Table 2).
Activity Profile and the Administration ofPGF2a
The administration of PGF2, immediately elicited contracture-like activity in both
the cervix and myometrium (Table 3). The cervix responded well to the .5 ,Rg * min-'
while in the myometrium, contracture-like activity was elicited at .2 ,ug * min-'. After
the withdrawal of the PGF2a, the electromyographic activity reappeared progressively
both in the cervical and myometrical EMG recording within five to eight minutes. It
was similar to that described during the control period (Fig. 1).
When the effect of PGF2, stimulation was maximal, i.e., .5 ,tg * min-' or 1.0 ,jg -
min-' as suggested by the highest level of electromyographic activity recorded, the
cervix and horns displayed continuous activity for the duration ofthe PGF2, infusions.
In addition, the response ofthe cervix and myometrium appeared to be in phase. By 12
hours after the cessation of the 4AA infusion, the uterine horns and the cervix
displayed regular electromyographic activity similar to those described during the
control period (Fig. 3).
TABLE 2
Frequency of EMG Epochs of <180 Seconds' and >180 Seconds' Duration per Two-Hour Period,
Recorded from Four Ovariectomized Non-Pregnant Sheep with Only Estradiol and with Both
Estradiol and 4AA (15 mg * min-' for four hours)
Cervix Myometrium
<180 Seconds >180 Seconds <180 Seconds >180 Seconds
WithE2 81 ±28 1.5±1.6 66± 19 2.8± 1.5
4AA + E2 84 ± 22 1.1 ± 0.9 74 ± 17 1.0 ± 0.8
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TABLE 3
Average Duration of EMG Epochs of >180 Seconds for a Two-Hour Period,
Recorded from Four Ovariectomized Non-Pregnant Sheep with 4AA Infusion at
15 mg * min- and During PGF7, Infusion .5kAg * minute for 10 minutes
(Data during PGF2, administration were obtained for ten minutes.)
Cervix Myometrium
>180 Seconds >180 Seconds
PGF2, alone 1,060 ± 25 960 ± 32
E2only 680 ± 700 720 ± 140
E2 + 4AA 432 ± 70 468 ± 44
E2 + 4AA + PGF2, 1,020 ± 40 1,074 + 26
Plasma Prostaglandin Concentration
Plasma PGFM (PGF2, metabolite) levels increased from 55 ± 5.5 pg * ml-' to
180 ± 215.4 pg * ml-' during estrogen replacement while 6-keto Fla (prostacyclin
metabolite) dropped from 58 ± 33.8 pg . ml-' to 25 ± 7.2 pg . ml-'.
During the administration of4AA, the plasma PGFM decreased from 180 ± 215.4
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FIG. 1. Electromyogram from a bilaterally ovariectomized non-pregnant ewe infused with saline. A,
myometrium left horn B, cervix C, myometrium left horn during PGF2, infusion (1.5 ,g.
min-') D, cervix during PGF2, infusion (.5,tg * min-').
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FIG. 2. Electromyogram for the same ewe as in Fig. 1 during continuous infusion of estradiol to the
maternal jugular vein at 100 ug * 24-'. A, myometrium left horn B, cervix C, myometrium
during 4AA infusion at 15 mg . min-' D, cervix during 4AA infusion at 15 mg * min-'.
to 47.0 ± 28.4 pg . ml-', compared to 6-keto Fla-25 ± 7.2 without 4AA to 34 ± 16.5
with 4AA. None ofthe above values were found to be statistically significant.
Without estradiol replacement the PGFM:6-keto Fla ratio in the plasma increased
proportionately with dose (r = .88, p < .05), while with estradiol replacement the
association was even more pronounced (r = .97, p < .01) (Table 4). Samples were
taken five minutes after the start ofinfusion.
DISCUSSION
In all four ewes studied, the cervix in the non-pregnant ewe demonstrated regular
EMG activity. The cervical EMG activity exhibited both similarities to, and differ-
ences from, the EMG recorded simultaneously from the myometrium. In the presence
of estradiol, there was no difference in the frequency of contractures, but the
myometrium demonstrated significantly more short epochs than the cervix. During
4AA treatment, the contracture activity of the myometrium significantly decreased
while thecervical contracture activity remained unchanged. There was an insignificant
increase in the frequency of short epochs both in the myometrium and cervix during
4AA administration. We have data, as yet unpublished, to suggest that 100 ,ug
estradiol * day-' is a supramaxial dose in regard to the myometrial EMG activity.
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FIG. 3. Electromyogram for the same ewe as in Fig. 2 after one hourof4AA to the maternal femoral vein
at 15 mg * min-' for four hours. A, myometrium left horn B, cervix C, myometrium left horn
during PGF2. infusion (.5 ,tg * min-') D, cervix during PGF2, infusion (.5 ,ug * min-').
Although an n number of 4 is too small a sample size on which to base treatment
effect, the reader might wonder whether or not we can accept as valid any statistical
conclusions drawn on the basis ofthis particular small sample. The truth ofthe matter
is that, as long as we have met the underlying assumptions for the statistical test, the
rejection of H0 at a .05 significance level is no more significant, statistically, when n is
large than when n is four. Since we used the .05 significance level and rejected H, the
changes in EMG activity in question are just as rare or unusual no matter how many
ewes we test. Ifanything, we might be more impressed by our rejection of no treatment
differences Ho with our small sample size of four.
There are several possible explanations ofthe mechanisms underlying the difference
between the myometrium and cervix in response to 4AA. It is possible that the changes
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in the other uterine tissues, such as the endometrium, do not play a significant role in
the cervix. The cervix may be more prone to sympathetic innervation [11,12].
Differences in local PGF2<r, prostacyclin production, and/or catabolism by the tissues
lining the uterine cavity might be one such mechanism. In addition, 4AA is thought, to
a great extent, to influence the blood flow to the uterus. It is quite possible that the
results may also be due to a difference in blood flow, and thus in the distribution of
4AA to the tissue ofthe myometrium and cervix. Another mechanism may result from
differences in the number of neurogenic receptors and in the number of gapjunctions
[13].
PGF2, given at low dosages did not elicit contracture-like EMG activity in the cervix
as viewed in the myometrium. This lack of responsiveness was less pronounced on
estrogen replacement. This finding may result from more PGF2.a receptors in the
myometrium. Alternatively, the greater response of the myometrium simply may
reflect histological differences [14].
Although there was lack of statistically significant changes in plasma PGFM and
6-keto Fla titers during estradiol replacement or 4AA administration, there appeared
to be an inverse relationship between these two metabolites. It has been suggested that
in some species, such as sheep and human, endogenous PGI2 of uterine origin may be
an inhibitor of myometrial activity in different states, including pregnancy. Such an
inhibition might be overcome by elevated PGF2a production at the tissue site [15].
However, as a result of the low statistical power of the test (n = 3), no conclusion is
warranted here. Therefore, these PGFM:6-keto Fl, trends may only providejustifica-
TABLE 4
The Mean ± SD of the PGFM:6-keto Fl Ratio from Three Non-Pregnant Ovariectomized Sheep
With or Without Estradiol and During the Administration of 4-amino-antipyrine
(Samples were collected five minutes within the PGF2a ten-minute infusion.)
Without EstradioL: With Estradiol:
PGFM:6-keto Fl. Ratio PGFM:6-keto Fla Ratio
Control 1.1 ± 0.5 6.9 ± 7.8
With 4AA Noexperiment 1.5 ± 1.1
PGF2< (jAg * min-') .0 2.4 ± 1.6 3.1 ± 1.6
.2 4.8 ± 4.5 7.7 ± 3.5
.5 11.7 ± 5.8 13.8 ± 5.3
1.0 14.0 ± 14.2 18.5 ± 13.5
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tion for generating a hypothesis concerning the interplay between PGF2a and prostacy-
clin in relation to EMG activity.
In conclusion, we suggest that electrophysiological differences between the cervix
and uterus may not result totally from mechanical properties or differences in blood
flow but may possibly represent differences in response to regulatory mechanisms. For
example, we have investigated the broad ligament (mesometrium) and found impor-
tant differences in regard to the response to estradiol replacement [accepted for
publication]. It is interesting to note that many of the (sympathetic postganglionic)
fibers which travel via the broad ligament converge at the border ofthe cervix [11,12].
It is known that a-adrenergic stimulation increases myometrial contractility by further
enhancing PGF2a and E2 synthesis whilef-adrenergic stimulation reduces contractility
by further enhancing 6-keto Fla production in pregnant human myometrial strips [15].
Unfortunately, no investigations have been conducted recording simultaneous cervical
and mesometrial EMG activity, measuring region;l differences in PG metabolites
under adrenergic stimulation or inhibition. Also, an appropriate in vitro model should
be searched for, enabling experimenters to circumvent possible systemic effects and to
allow one to focus at the tissue level. Such investigations may further enable us to
elucidate or describe possible mechanisms ofcontrol and/or regulation.
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